Iambic Therapeutics S-1/A amended IPO filing; offering price range $15-17 per share, 9.38M shares for $150M at midpoint

Iambic amended its IPO registration with pricing details: 9.38 million shares at $15-17 per share, targeting $150M in gross proceeds. The company has raised $461.8M to date from investors including NVIDIA, Nexus Ventures, Catalio, and Coatue.